• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RAF1 突变体与 noonan 综合征相关,其共同的致病机制是 BRAF 异二聚体的形成增加。

Increased BRAF heterodimerization is the common pathogenic mechanism for noonan syndrome-associated RAF1 mutants.

机构信息

Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.

出版信息

Mol Cell Biol. 2012 Oct;32(19):3872-90. doi: 10.1128/MCB.00751-12. Epub 2012 Jul 23.

DOI:10.1128/MCB.00751-12
PMID:22826437
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3457534/
Abstract

Noonan syndrome (NS) is a relatively common autosomal dominant disorder characterized by congenital heart defects, short stature, and facial dysmorphia. NS is caused by germ line mutations in several components of the RAS-RAF-MEK-extracellular signal-regulated kinase (ERK) mitogen-activated protein kinase (MAPK) pathway, including both kinase-activating and kinase-impaired alleles of RAF1 (∼3 to 5%), which encodes a serine-threonine kinase for MEK1/2. To investigate how kinase-impaired RAF1 mutants cause NS, we generated knock-in mice expressing Raf1(D486N). Raf1(D486N/+) (here D486N/+) female mice exhibited a mild growth defect. Male and female D486N/D486N mice developed concentric cardiac hypertrophy and incompletely penetrant, but severe, growth defects. Remarkably, Mek/Erk activation was enhanced in Raf1(D486N)-expressing cells compared with controls. RAF1(D486N), as well as other kinase-impaired RAF1 mutants, showed increased heterodimerization with BRAF, which was necessary and sufficient to promote increased MEK/ERK activation. Furthermore, kinase-activating RAF1 mutants also required heterodimerization to enhance MEK/ERK activation. Our results suggest that an increased heterodimerization ability is the common pathogenic mechanism for NS-associated RAF1 mutations.

摘要

努南综合征(Noonan syndrome,NS)是一种相对常见的常染色体显性遗传病,其特征为先天性心脏缺陷、身材矮小和面部畸形。NS 由 RAS-RAF-MEK-细胞外信号调节激酶(extracellular signal-regulated kinase,ERK)丝裂原活化蛋白激酶(mitogen-activated protein kinase,MAPK)通路中几个成分的种系突变引起,包括 RAF1 的激酶激活和激酶失活等位基因(约 3%~5%),后者编码 MEK1/2 的丝氨酸-苏氨酸激酶。为了研究激酶失活 RAF1 突变体如何引起 NS,我们生成了表达 Raf1(D486N)的基因敲入小鼠。Raf1(D486N/+)(这里表示 D486N/+)雌性小鼠表现出轻度生长缺陷。雄性和雌性 D486N/D486N 小鼠出现同心性心肌肥厚和不完全穿透性但严重的生长缺陷。值得注意的是,与对照相比,Raf1(D486N)表达细胞中的 Mek/Erk 激活增强。与 RAF1(D486N)一样,其他激酶失活 RAF1 突变体与 BRAF 的异二聚化增加,这对于促进 Mek/ERK 激活是必要且充分的。此外,激酶激活 RAF1 突变体也需要异二聚化来增强 Mek/ERK 激活。我们的结果表明,增加的异二聚化能力是 NS 相关 RAF1 突变的共同致病机制。

相似文献

1
Increased BRAF heterodimerization is the common pathogenic mechanism for noonan syndrome-associated RAF1 mutants.RAF1 突变体与 noonan 综合征相关,其共同的致病机制是 BRAF 异二聚体的形成增加。
Mol Cell Biol. 2012 Oct;32(19):3872-90. doi: 10.1128/MCB.00751-12. Epub 2012 Jul 23.
2
MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1(L613V) mutation.MEK-ERK 通路调节改善了伴有 Raf1(L613V)突变的诺南综合征小鼠模型的疾病表型。
J Clin Invest. 2011 Mar;121(3):1009-25. doi: 10.1172/JCI44929. Epub 2011 Feb 21.
3
RSK3 is required for concentric myocyte hypertrophy in an activated Raf1 model for Noonan syndrome.在努南综合征的激活型Raf1模型中,同心性心肌细胞肥大需要RSK3。
J Mol Cell Cardiol. 2016 Apr;93:98-105. doi: 10.1016/j.yjmcc.2016.02.020. Epub 2016 Mar 3.
4
Inducible Pluripotent Stem Cell-Derived Cardiomyocytes Reveal Aberrant Extracellular Regulated Kinase 5 and Mitogen-Activated Protein Kinase Kinase 1/2 Signaling Concomitantly Promote Hypertrophic Cardiomyopathy in RAF1-Associated Noonan Syndrome.诱导多能干细胞衍生的心肌细胞揭示异常细胞外调节激酶 5 和丝裂原活化蛋白激酶激酶 1/2 信号同时促进 RAF1 相关诺南综合征中的肥厚型心肌病。
Circulation. 2019 Jul 16;140(3):207-224. doi: 10.1161/CIRCULATIONAHA.118.037227. Epub 2019 Jun 5.
5
Cyclosporine attenuates cardiomyocyte hypertrophy induced by RAF1 mutants in Noonan and LEOPARD syndromes.环孢菌素可减轻诺南综合征和莱-泼恩综合征中 RAF1 突变体诱导的心肌细胞肥大。
J Mol Cell Cardiol. 2011 Jul;51(1):4-15. doi: 10.1016/j.yjmcc.2011.03.001. Epub 2011 Apr 8.
6
Cellular interplay via cytokine hierarchy causes pathological cardiac hypertrophy in RAF1-mutant Noonan syndrome.细胞间通过细胞因子级联作用导致 RAF1 突变型努南综合征的病理性心肌肥厚。
Nat Commun. 2017 May 26;8:15518. doi: 10.1038/ncomms15518.
7
RAF1/BRAF dimerization integrates the signal from RAS to ERK and ROKα.RAF1/BRAF二聚化整合了从RAS到ERK和ROKα的信号。
Sci Signal. 2017 Mar 7;10(469):eaai8482. doi: 10.1126/scisignal.aai8482.
8
Molecular and clinical analysis of RAF1 in Noonan syndrome and related disorders: dephosphorylation of serine 259 as the essential mechanism for mutant activation.NRAS 信号通路相关疾病 RAF1 基因突变的分子和临床分析:丝氨酸 259 去磷酸化是 RAF1 突变激活的关键机制。
Hum Mutat. 2010 Mar;31(3):284-94. doi: 10.1002/humu.21187.
9
Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy.功能获得性RAF1突变导致伴有肥厚型心肌病的努南综合征和豹皮综合征。
Nat Genet. 2007 Aug;39(8):1007-12. doi: 10.1038/ng2073. Epub 2007 Jul 1.
10
Targeted/exome sequencing identified mutations in ten Chinese patients diagnosed with Noonan syndrome and related disorders.靶向/外显子组测序在10名被诊断患有努南综合征及相关疾病的中国患者中发现了突变。
BMC Med Genomics. 2017 Oct 30;10(1):62. doi: 10.1186/s12920-017-0298-6.

引用本文的文献

1
Sterigmatocystin declines mouse oocyte quality by inducing ferroptosis and asymmetric division defects.表靘菌素通过诱导铁死亡和不对称分裂缺陷降低小鼠卵母细胞质量。
J Ovarian Res. 2024 Aug 28;17(1):175. doi: 10.1186/s13048-024-01499-w.
2
Conformational diversity and protein-protein interfaces in drug repurposing in Ras signaling pathway.在 Ras 信号通路中重新利用药物时的构象多样性和蛋白质-蛋白质界面。
Sci Rep. 2024 Jan 12;14(1):1239. doi: 10.1038/s41598-023-50913-8.
3
The role of CRAF in cancer progression: from molecular mechanisms to precision therapies.CRAF 在癌症进展中的作用:从分子机制到精准治疗。
Nat Rev Cancer. 2024 Feb;24(2):105-122. doi: 10.1038/s41568-023-00650-x. Epub 2024 Jan 9.
4
Analysis of RAS and drug induced homo- and heterodimerization of RAF and KSR1 proteins in living cells using split Nanoluc luciferase.利用拆分 Nanoluc 荧光素酶在活细胞中分析 RAS 以及 RAF 和 KSR1 蛋白的药物诱导同型和异型二聚化。
Cell Commun Signal. 2023 Jun 14;21(1):136. doi: 10.1186/s12964-023-01146-9.
5
RAF1 deficiency causes a lethal syndrome that underscores RTK signaling during embryogenesis.RAF1 缺陷导致一种致命综合征,强调了胚胎发生过程中 RTK 信号传导的作用。
EMBO Mol Med. 2023 May 8;15(5):e17078. doi: 10.15252/emmm.202217078. Epub 2023 Apr 17.
6
Cross-species analysis of LZTR1 loss-of-function mutants demonstrates dependency to RIT1 orthologs.跨物种分析 LZTR1 功能丧失突变体表明对 RIT1 同源物的依赖性。
Elife. 2022 Apr 25;11:e76495. doi: 10.7554/eLife.76495.
7
The RASopathies: from pathogenetics to therapeutics.RAS 相关疾病:从发病机制到治疗学。
Dis Model Mech. 2022 Feb 1;15(2). doi: 10.1242/dmm.049107. Epub 2022 Feb 18.
8
RAF kinase dimerization: implications for drug discovery and clinical outcomes.RAF 激酶二聚化:对药物发现和临床结果的影响。
Oncogene. 2020 May;39(21):4155-4169. doi: 10.1038/s41388-020-1263-y. Epub 2020 Apr 8.
9
Comparative analysis of functional assay evidence use by ClinGen Variant Curation Expert Panels.ClinGen 变异解读专家小组对功能检测证据的使用进行比较分析。
Genome Med. 2019 Nov 29;11(1):77. doi: 10.1186/s13073-019-0683-1.
10
Development of Allosteric BRAF Peptide Inhibitors Targeting the Dimer Interface of BRAF.靶向 BRAF 二聚体界面的别构 BRAF 肽抑制剂的开发。
ACS Chem Biol. 2019 Jul 19;14(7):1471-1480. doi: 10.1021/acschembio.9b00191. Epub 2019 Jun 17.

本文引用的文献

1
Mutational patterns and novel mutations of the BRAF gene in a large cohort of Korean patients with papillary thyroid carcinoma.在一个大型韩国甲状腺乳头状癌患者队列中 BRAF 基因的突变模式和新突变。
Thyroid. 2012 Aug;22(8):791-7. doi: 10.1089/thy.2011.0123. Epub 2012 Apr 3.
2
Raf family kinases: old dogs have learned new tricks.Raf家族激酶:老骥伏枥,志在新功。
Genes Cancer. 2011 Mar;2(3):232-60. doi: 10.1177/1947601911407323.
3
Cyclosporine attenuates cardiomyocyte hypertrophy induced by RAF1 mutants in Noonan and LEOPARD syndromes.环孢菌素可减轻诺南综合征和莱-泼恩综合征中 RAF1 突变体诱导的心肌细胞肥大。
J Mol Cell Cardiol. 2011 Jul;51(1):4-15. doi: 10.1016/j.yjmcc.2011.03.001. Epub 2011 Apr 8.
4
Noonan syndrome and clinically related disorders.努南综合征及相关临床疾病。
Best Pract Res Clin Endocrinol Metab. 2011 Feb;25(1):161-79. doi: 10.1016/j.beem.2010.09.002.
5
MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1(L613V) mutation.MEK-ERK 通路调节改善了伴有 Raf1(L613V)突变的诺南综合征小鼠模型的疾病表型。
J Clin Invest. 2011 Mar;121(3):1009-25. doi: 10.1172/JCI44929. Epub 2011 Feb 21.
6
Activation of multiple signaling pathways causes developmental defects in mice with a Noonan syndrome–associated Sos1 mutation.多个信号通路的激活导致伴有 Noonan 综合征相关 Sos1 突变的小鼠出现发育缺陷。
J Clin Invest. 2010 Dec;120(12):4353-65. doi: 10.1172/JCI43910.
7
Impaired binding of 14-3-3 to C-RAF in Noonan syndrome suggests new approaches in diseases with increased Ras signaling.诺南综合征中 14-3-3 与 C-RAF 结合能力受损表明在 Ras 信号转导增加的疾病中存在新的治疗方法。
Mol Cell Biol. 2010 Oct;30(19):4698-711. doi: 10.1128/MCB.01636-09. Epub 2010 Aug 2.
8
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF.RAF 抑制剂可使野生型 BRAF 细胞中的 RAF 二聚体和 ERK 信号转导激活。
Nature. 2010 Mar 18;464(7287):427-30. doi: 10.1038/nature08902.
9
Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF.激酶失活的 BRAF 和致癌性的 RAS 通过 CRAF 合作驱动肿瘤进展。
Cell. 2010 Jan 22;140(2):209-21. doi: 10.1016/j.cell.2009.12.040.
10
RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth.RAF 抑制剂使野生型 RAF 激活 MAPK 通路并增强其生长。
Nature. 2010 Mar 18;464(7287):431-5. doi: 10.1038/nature08833. Epub 2010 Feb 3.